HLv2.x is a messaging protocol that was mainly based on ascii / text and also supported xml support. The problem was that HL7v2.x had the margin to configure up to about 20 percent. Therefore, several times HL7 also referred to as an open standard.
To undo the configuration, achieve consistency and enable Plug N Play messaging, RIM - Reference Information Model . This gave an object-oriented approach to the HL7 messaging standard.
Based on RIM, the CDA Clinical Document Architecture was developed. If you say that you use v3 or CDA, then they mean the same . The v3 post is entirely XML-based, not allowing scope for customization unlike v2.7.
UPDATE . This question here also contains additional information about the schemes used by v3 and CDA.
Key Differences
HL7 V2
- Not “Plug and Play” - it provides 80 percent of the interface and a framework for matching the remaining 20 percent based on interface by interface.
- Historically built in a special way, since at that time there was no other standard
- Generally provides 2.X compatibility
- A standard based on messaging, built on the basis of coding for channels and hats
- V2 is what most people think when people say "HL7"
Hl7 v3
- “Plug and Play” Approach - Less “Negotiating Framework”
- Many decades of effort over ten years reflecting “best and bright” thinking NOT backward compatible with V2
- A model-based standard based on a reference information model (RIM) ensures consistency across the standard.
- Messages in XML format.
- Clinical Document Architecture (CDA) is what most people think when people say "HL7 V3"
Example
v3
<author> <time value="200202150730"/> <modeCode code="WRITTEN"/> <signatureCode code="S"/> <assignedEntity> <id root="2.16.840.1.113883.19.1122.3" extension="444-444-4444"/> <assignedPerson> <name> <given>Harold</given> <given>H</given> <family>Hippocrates</family> <suffix qualifier="AC">MD</suffix> </name> </assignedPerson> </assignedEntity>
v3 is in continuous development. Even today, most healthcare applications continue to use v2.x.
Sid
source share